Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
200 participants
INTERVENTIONAL
2016-03-31
2016-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Oral Hyoscine Butyl Bromide Versus Diclofenac Potassium Before Office Hysteroscopy
NCT02714699
How to Reduce Pain in Patients Undergoing Office Hysteroscopy.
NCT05911126
A Study to Investigate the Analgesic Efficacy of Ibuprofen Alone and Ibuprofen Plus Hyoscine-n- Butyl Bromide in Reducing Pain of Outpatient Hysteroscopy
NCT06398054
Oral Diclofenac Sodium Versus Oral Hyoscine Butyl Bromide During Intrauterine Device Insertion
NCT02714231
Ketoprofen With or Without Vaginal Isonicotinic Acid Hydrazide Prior to Hysterosalpingography
NCT04500470
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group A
oral hyoscine butyl bromide; 2 tablets (buscopan 10 mg) 30 minutes before the procedure
hyoscine butyl bromide
oral hyoscine butyl bromide; 2 tablets (buscopan 10 mg) 30 minutes before the procedure
Group B
oral 2 tablets (PLACEBO) 30 minutes before the procedure
placebo
oral placebo; 2 tablets 30 minutes before the procedure
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
hyoscine butyl bromide
oral hyoscine butyl bromide; 2 tablets (buscopan 10 mg) 30 minutes before the procedure
placebo
oral placebo; 2 tablets 30 minutes before the procedure
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* known sensitivity to contrast media
* abnormal uterine bleeding
* genital tract infection
* suspected pregnancy
20 Years
42 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ahmed Mohamed Abbas
Dr
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
ahmed abbas, MD
Role: PRINCIPAL_INVESTIGATOR
Woman health hospital Assiut
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ahmed Abbas
Assiut, Cairo Governorate, Egypt
Ahmed Abbas
Asyut, Please Select, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HS2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.